| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Yong Jun Tu CEO | XSHE Exchange | CNE1000034X1 ISIN |
| CN Country | 4,532 Employees | 2 Jun 2026 Last Dividend | 12 Jun 2018 Last Split | - IPO Date |
Zhejiang Tianyu Pharmaceutical Co., Ltd. is a prominent player in the pharmaceutical industry, specializing in the research, development, manufacture, and sale of pharmaceutical intermediates and Active Pharmaceutical Ingredients (APIs). Established in 1993 and headquartered in Taizhou, China, the company has expanded its reach to serve not only the domestic market but also an international clientele. Zhejiang Tianyu Pharmaceutical is dedicated to contributing to the healthcare industry by focusing on key therapeutic areas such as cardiovascular, anti-diabetic, atherosclerosis, anticoagulant, and anti-asthmatic treatments.
Zhejiang Tianyu Pharmaceutical offers a diverse range of pharmaceutical intermediates and APIs, focusing on essential therapeutic classes. This includes treatments for cardiovascular diseases, anti-diabetic medications, solutions for atherosclerosis, anticoagulants, and anti-asthmatic drugs. These products are critical components for the development and manufacturing of various medications, addressing some of the most pressing health issues faced by the population today.
The company also specializes in the production of fine chemicals, which are high-quality chemicals produced in limited quantities for specialized applications. These fine chemicals are used in a variety of industries, including pharmaceuticals, for their precise specifications and high degree of purity.
Zhejiang Tianyu Pharmaceutical provides Contract Development and Manufacturing Organization (CDMO) services, offering customized solutions for the development and manufacturing of pharmaceutical products. Through these services, partner organizations can leverage Zhejiang Tianyu's expertise, infrastructure, and technology to bring their pharmaceutical products to the market more efficiently and economically.